TipRanks
InDex Pharmaceuticals Holding AB (DE:1NP1)
FRANKFURT:1NP1
Germany Market
1NP1
InDex Pharmaceuticals Holding AB
RESEARCH TOOLSreports

InDex Pharmaceuticals Holding AB (1NP1) Ratios

5 Followers

InDex Pharmaceuticals Holding AB Ratios

DE:1NP1's free cash flow for Q2 2026 was kr7.50. For the 2026 fiscal year, DE:1NP1's free cash flow was decreased by kr and operating cash flow was kr12.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 66.45 52.31 55.39 5.04 23.57
Quick Ratio
 66.45 52.31 55.39 5.04 23.57
Cash Ratio
 36.39 38.86 46.76 5.00 23.41
Solvency Ratio
 -52.71 -37.26 -8.99 -1.55 -5.71
Operating Cash Flow Ratio
 -4.46 -2.02 -0.92 -0.64 -8.78
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -42.50 0.00 0.00
Net Current Asset Value
kr 542.40Mkr 706.80Mkr 999.40Mkr 236.11Mkr 329.97M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.00 1.01 1.01 1.25 1.05
Debt Service Coverage Ratio
 -54.70 -54.20 -53.81 -413.31 -826.23
Interest Coverage Ratio
 -67.81 -57.09 -29.16 -472.98 -1.26K
Debt to Market Cap
 0.00 0.00 <0.01 0.00 0.00
Interest Debt Per Share
 0.17 0.20 0.07 0.05 0.06
Net Debt to EBITDA
 0.41 0.72 3.83 3.11 3.45
Profitability Margins
Gross Profit Margin
201.43%-144.32%-41600.00%95.74%0.00%
EBIT Margin
3515.24%-8456.82%-226500.00%-97.47%0.00%
EBITDA Margin
3512.38%-8450.00%-225900.00%-96.22%0.00%
Operating Profit Margin
4391.43%-8887.50%-110800.00%-110.11%0.00%
Pretax Profit Margin
3938.10%-8612.50%-227900.00%-97.70%0.00%
Net Profit Margin
3968.57%-8601.14%-228000.00%-97.70%0.00%
Continuous Operations Profit Margin
3968.57%-8601.14%-228000.00%-97.70%0.00%
Net Income Per EBT
100.77%99.87%100.04%100.00%100.00%
EBT Per EBIT
89.68%96.91%205.69%88.73%66.40%
Return on Assets (ROA)
-24.44%-22.28%-5.40%-31.82%-28.56%
Return on Equity (ROE)
-23.22%-22.41%-5.43%-39.88%-30.04%
Return on Capital Employed (ROCE)
-27.11%-23.12%-2.64%-44.65%-44.89%
Return on Invested Capital (ROIC)
-27.11%-23.08%-2.63%-44.52%-44.81%
Return on Tangible Assets
-24.44%-22.28%-5.40%-31.82%-28.56%
Earnings Yield
-52.88%-29.63%-7.88%-3.32%-3.50%
Efficiency Ratios
Receivables Turnover
 -0.09 0.04 <0.01 42.52 0.00
Payables Turnover
 15.21 15.36 69.50 0.62 0.16
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 -15.00 5.18 0.10 35.16 0.00
Asset Turnover
 >-0.01 <0.01 <0.01 0.33 0.00
Working Capital Turnover Ratio
 -0.03 0.01 <0.01 0.34 0.00
Cash Conversion Cycle
 -4.30K 9.44K 539.10K -583.42 -2.25K
Days of Sales Outstanding
 -4.28K 9.47K 539.11K 8.58 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 23.99 23.77 5.25 592.01 2.25K
Operating Cycle
 -4.28K 9.47K 539.11K 8.58 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.41 -0.36 -0.24 -0.71 -2.43
Free Cash Flow Per Share
 -0.41 -0.36 -0.24 -0.71 -2.43
CapEx Per Share
 0.04 0.36 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -11.36 -1.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 -11.36 -1.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -22.06 -13.38 -21.25 -16.53 -39.80
Operating Cash Flow to Sales Ratio
 1.79 -3.19 -170.00 -0.39 0.00
Free Cash Flow Yield
-2.49%-1.10%-0.59%-1.33%-4.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.64 -3.37 -12.68 -30.08 -28.56
Price-to-Sales (P/S) Ratio
 -71.63 290.28 28.95K 29.39 0.00
Price-to-Book (P/B) Ratio
 0.46 0.76 0.69 12.00 8.58
Price-to-Free Cash Flow (P/FCF) Ratio
 -40.11 -90.91 -170.29 -75.46 -22.14
Price-to-Operating Cash Flow Ratio
 -42.03 -90.91 -170.29 -75.46 -22.14
Price-to-Earnings Growth (PEG) Ratio
 0.01 -0.02 0.15 5.90 2.46
Price-to-Fair Value
 0.46 0.76 0.69 12.00 8.58
Enterprise Value Multiple
 -1.63 -2.71 -8.99 -27.43 -25.46
Enterprise Value
 1.20B 2.02B 2.03B 2.57B 2.52B
EV to EBITDA
 -1.63 -2.71 -8.99 -27.43 -25.46
EV to Sales
 -57.15 229.13 20.31K 26.40 0.00
EV to Free Cash Flow
 -32.01 -71.76 -119.45 -67.78 -19.50
EV to Operating Cash Flow
 -32.01 -71.76 -119.45 -67.78 -19.50
Tangible Book Value Per Share
 37.36 43.32 59.57 4.48 6.27
Shareholders’ Equity Per Share
 37.36 43.32 59.57 4.48 6.27
Tax and Other Ratios
Effective Tax Rate
 >-0.01 <0.01 >-0.01 0.00 0.00
Revenue Per Share
 -0.23 0.11 <0.01 1.83 0.00
Net Income Per Share
 -9.17 -9.71 -3.24 -1.79 -1.88
Tax Burden
 1.01 1.00 1.00 1.00 1.00
Interest Burden
 1.12 1.02 1.01 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 69.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.05 0.04 0.07 0.40 1.29
Currency in SEK